Type 2 Diabetes. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention:
patients in the treatment group received 1500 mg probiotic capsules twice daily (after lunch and dinner meals) for 6 weeks. The lactobacillus Probiotics contain:
L. acid
Treatment - Drugs
Placebo
Control:
Placebo Group receiving 1500 mg Magnesium Stearate capsules twice daily, for six weeks.
Intervention:
patients in the treatment group received 1500 mg probiotic capsules twice daily (after lunch and dinner meals) for 6 weeks. The lactobacillus Probiotics contain:
L. acidophilus
Sponsors
Researches and Technology Deputy of Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
25 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Patients with diabetes type 2 were enrolled with FBS = 126 mgr / dl ; less than 15 years of their disease were over ; the age range was 25 to 65 years ; Elective subjects, next drugs prescribed by doctors, should be controlled the status of glucose and lipid levels and during the study could use of these drugs without changing in the prior dosage. Exclusion Criteria: Patients with diabetes type 2 that used replace treatments like Hormone or supplemental vitamin ; Also those used tobacco and alcohol ; patients with chronic kidney disease ; liver ; lung ; chronic or acute inflammatory disease (especially acute pancreatic inflammation and Endocarditis) ; heart valve disease ; short bowel syndrome ; allergies ; people with low immune system ability (autoimmune) ; pregnant or lactating women.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lipid Profile ( Tg,Total Chol, LDL-C, HDL-C ). Timepoint: Before and After Intervention. Method of measurement: Autoanalyzer.;Serum Glucose. Timepoint: Before and after Intervention. Method of measurement: Autoanalyzer.;Serum Insulin Levels. Timepoint: Before and After Intervention. Method of measurement: ELISA.;Hs-CRP. Timepoint: Before and after intervention. Method of measurement: ELISA.;IL-6. Timepoint: Before and After Intervention. Method of measurement: Autoanalyzer.;Malodialdehyde (MDA). Timepoint: Before and after Intervention. Method of measurement: Specterophotometery. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbbas Yousefinejad
Tehran University of Medical sciences
Outcome results
None listed